Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Tradies aren’t protecting against skin cancer despite up to ten times higher UV exposure
New data reveals that Australia’s tradies aren’t acting to protect themselves from the sun despite…
Deep-sea microbe provides rich source of anticancer molecule
The anti-cancer molecule salinosporamide A, also called Marizomb, is in Phase III clinical trials to treat…
How accelerated biological aging may cause bowel cancer
Scientists have shown how accelerated biological aging measured by an epigenetic clock may increase the…
Is cancer fundraising fuelling quackery?
Figures published by The BMJ today show how crowdfunding for alternative therapies for patients with terminal cancer has soared in recent years.…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.